| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.59B | 105.55B | 89.03B | 77.81B | 71.83B | 69.64B |
| Gross Profit | 8.52B | 11.95B | 8.28B | 5.65B | 5.38B | 6.05B |
| EBITDA | 4.31B | 7.05B | 4.23B | 2.23B | 2.06B | 2.83B |
| Net Income | 2.18B | 3.80B | 2.06B | 1.24B | 1.32B | 1.82B |
Balance Sheet | ||||||
| Total Assets | 56.68B | 59.65B | 55.59B | 59.11B | 45.63B | 48.66B |
| Cash, Cash Equivalents and Short-Term Investments | 4.52B | 10.78B | 4.46B | 8.78B | 10.19B | 7.52B |
| Total Debt | 10.12B | 2.75B | 3.20B | 4.67B | 202.00M | 378.00M |
| Total Liabilities | 33.76B | 34.44B | 32.60B | 36.56B | 24.09B | 28.03B |
| Stockholders Equity | 22.92B | 25.21B | 22.99B | 22.55B | 21.54B | 20.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.14B | -3.71B | -2.65B | 3.53B | 1.85B |
| Operating Cash Flow | 0.00 | 9.30B | -3.06B | -1.92B | 4.19B | 1.96B |
| Investing Cash Flow | 0.00 | -305.00M | 808.00M | -2.99B | -516.00M | -122.00M |
| Financing Cash Flow | 0.00 | -2.68B | -2.07B | 3.70B | -1.01B | -535.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥33.97B | 8.76 | ― | 3.86% | 18.56% | 86.25% | |
71 Outperform | ¥36.97B | 5.76 | ― | 3.01% | 7.25% | 36.43% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥41.89B | 7.74 | ― | 6.02% | -5.07% | -26.79% | |
59 Neutral | ¥6.16B | 12.20 | 2.90% | 4.53% | -12.48% | -34.07% | |
58 Neutral | ¥121.77B | 20.27 | 4.48% | 3.30% | 3.93% | 16.91% | |
56 Neutral | ¥55.08B | 11.83 | 6.98% | 7.35% | 9.08% | -42.76% |